Epidemiology of Diabetes Interventions and Complications (EDIC)
Recruitment status was Active, not recruiting
OBJECTIVE— The Diabetes Control and Complications Trial (DCCT) demonstrated the powerful impact of glycemic control on the early manifestations of microvascular complications.
Contemporary prospective data on the evolution of macrovascular and late micro vascular complications of type 1 diabetes are limited. The Epidemiology of Diabetes Interventions and Complications (EDIC) study is a multicenter, longitudinal, observational study designed to use the well-characterized DCCT cohort of 1,400 patients to determine the long-term effects of prior separation of glycemic levels on micro- and macrovascular outcomes. EDIC is in its 13th year of followup. The study is expecting to last until 2016.
RESEARCH DESIGN AND METHODS— Using a standardized annual history and physical examination, 28 EDIC clinical centers that were DCCT clinics will follow the EDIC cohort for 10 years. Annual evaluation also includes resting electro c a rdiogram, Doppler ultrasound measurements of ankle/arm blood pressure, and screening for nephropathy. At regular intervals, a timed 4-h urine is collected, lipid pro files are obtained, and stereoscopic fundus photographs are taken. In addition, dual B-mode Doppler ultrasound scans of the common and internal carotid arteries will be perf o rmed at years 1 and 6 and at study end.
Type 1 Diabetes Mellitus
|Study Design:||Time Perspective: Prospective|
|Official Title:||Epidemiology of Diabetes Interventions and Complications (EDIC)|
|Study Start Date:||April 1994|
|Estimated Study Completion Date:||February 2016|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00360893
Show 40 Study Locations
|Study Chair:||Saul M. Genuth, M.D.||Case Western Reserve University|
|Study Chair:||David M. Nathan, M.D.||Massachusetts General Hospital|
|Study Director:||Catherine Cowie, Ph.D.||National Institutes of Health, Naitonal Institute of Diabetes and Digestive and Kidney Diseases|
|Principal Investigator:||William Dahms, M.D.||Case Western Reserve University|
|Principal Investigator:||Patricia A Cleary, M.S.||George Washington University|
|Principal Investigator:||John M. Lachin, Sc.D.||George Washington University|
|Principal Investigator:||Bernard Zinman, M.D., F.A.C.P.||University of Toronto, Mount Sinai Hospital|
|Principal Investigator:||Mark Palmert, Ph.D.||Case Western Reserve University|